Moderna files for FDA authorization for the Covid vaccine in recent adolescents, teenagers deleted by the FDA, which is clarified by the FDA, is the moderna of the second Covid 19 vaccine, which in the US for teenagers under 18 years Together with Pfizer-Biontechs vaccine available.
Moderna files for FDA authorization for the Covid vaccine in recent adolescents, teenagers
Moderna on Thursday, filed for the emergency use approval of food and drug management, to use its Covid 19 vaccine in adolescents between 12 to 17 years, it will be from the FDA deleted the second Covid-19 vaccine available in the United States for young people under 180 together with the Pfizer Biontech vaccine authorized for young people aged 12 to 15 years in May.
The Moderna said in May, which gave himself from his clinical trial among children 12 to 17 years, showed that the two-dose mRNA vaccine is safe and very effective.
The study included more than 3,700 participants
Side effects were generally mild or moderate, said the company.
The injection site was the most common side effect after the first dose and headache, fatigue, muscle aches and chilling were most common after the second dose.
“We are encouraged that the Moderna Covid-19 vaccine was highly effective at preventing Covid-19 and SARS-CoV-2 infection in adolescents,” Moderna CEO Stéphane Bancel, said Thursday in one Explanation.